450 related articles for article (PubMed ID: 28664547)
1. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes.
Verouti SN; Tsilibary EC; Fragopoulou E; Iatrou C; Demopoulos CA; Charonis AS; Charonis SA; Drossopoulou GI
Nephron Exp Nephrol; 2012; 122(1-2):36-50. PubMed ID: 23548800
[TBL] [Abstract][Full Text] [Related]
3. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM
Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009
[TBL] [Abstract][Full Text] [Related]
4. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model.
Nakhoul N; Thawko T; Farber E; Dahan I; Tadmor H; Nakhoul R; Hanut A; Salameh G; Shagrawy I; Nakhoul F
J Diabetes Res; 2020; 2020():7907605. PubMed ID: 33294462
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D prevents podocyte injury via regulation of macrophage M1/M2 phenotype in diabetic nephropathy rats.
Zhang XL; Guo YF; Song ZX; Zhou M
Endocrinology; 2014 Dec; 155(12):4939-50. PubMed ID: 25188527
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
[TBL] [Abstract][Full Text] [Related]
7. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
Zhang X; Song Z; Guo Y; Zhou M
Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
[TBL] [Abstract][Full Text] [Related]
8. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.
Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P
J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734
[TBL] [Abstract][Full Text] [Related]
9. The PI3K/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats.
Song Z; Guo Y; Zhou M; Zhang X
Metabolism; 2014 Oct; 63(10):1324-33. PubMed ID: 25044177
[TBL] [Abstract][Full Text] [Related]
10. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease.
Zhang X; Zhang L; Wen Y; Zhang M; Liu S; Xiao H
Kidney Blood Press Res; 2023; 48(1):314-325. PubMed ID: 37054686
[TBL] [Abstract][Full Text] [Related]
12. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D/vitamin D receptor/Atg16L1 axis maintains podocyte autophagy and survival in diabetic kidney disease.
Shi L; Xiao C; Zhang Y; Xia Y; Zha H; Zhu J; Song Z
Ren Fail; 2022 Dec; 44(1):694-705. PubMed ID: 35469547
[TBL] [Abstract][Full Text] [Related]
14. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling.
Ha TS; Hong EJ; Han GD
Diabetes Metab Res Rev; 2015 Jan; 31(1):50-60. PubMed ID: 24846128
[TBL] [Abstract][Full Text] [Related]
15. Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell.
Liu Y; Li L; Yi B; Hu ZX; Li AM; Yang C; Zheng L; Zhang H
Life Sci; 2019 Oct; 234():116755. PubMed ID: 31415769
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy.
Doublier S; Zennaro C; Spatola T; Lupia E; Bottelli A; Deregibus MC; Carraro M; Conaldi PG; Camussi G
AIDS; 2007 Feb; 21(4):423-32. PubMed ID: 17301560
[TBL] [Abstract][Full Text] [Related]
17. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
18. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
[TBL] [Abstract][Full Text] [Related]
19. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH
Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888
[TBL] [Abstract][Full Text] [Related]
20. Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice.
Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH
Acta Pharmacol Sin; 2017 Aug; 38(8):1129-1140. PubMed ID: 28502979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]